[posting]59884573[/posting]aus der 2018Q4-Präsi:
Balancing Near-term Execution with Long-term Vision: The Challenges in 2019
• Ongoing pharmacy reimbursement pressures in our businesses and reduction in offsets to those pressures, including a declining benefit from generics
• Lower brand inflation and ongoing questions around rebates
• Structural and CVS-specific challenges in long-term care space
These challenges are having a disproportionate impact compared to prior years
=> daher die Ernüchterung gestern mit -8% =>
